Cargando…
A multidisciplinary approach to screen the post-COVID-19 conditions
BACKGROUND: Post-COronaVIrus Disease 2019 (COVID-19) conditions (PCC) include multiple symptoms afflicting different organs and systems. To evaluate the frequency and type of them, we described our multidisciplinary approach with preliminary results of the first enrolled patients. METHODS: We includ...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9872735/ https://www.ncbi.nlm.nih.gov/pubmed/36694110 http://dx.doi.org/10.1186/s12879-023-08006-4 |
_version_ | 1784877463927521280 |
---|---|
author | Squillace, Nicola Cogliandro, Viola Rossi, Emanuela Bellelli, Giuseppe Pozzi, Matteo Luppi, Fabrizio Lettino, Maddalena Strepparava, Maria Grazia Ferrarese, Carlo Pollastri, Ester Ricci, Elena Bonfanti, Paolo |
author_facet | Squillace, Nicola Cogliandro, Viola Rossi, Emanuela Bellelli, Giuseppe Pozzi, Matteo Luppi, Fabrizio Lettino, Maddalena Strepparava, Maria Grazia Ferrarese, Carlo Pollastri, Ester Ricci, Elena Bonfanti, Paolo |
author_sort | Squillace, Nicola |
collection | PubMed |
description | BACKGROUND: Post-COronaVIrus Disease 2019 (COVID-19) conditions (PCC) include multiple symptoms afflicting different organs and systems. To evaluate the frequency and type of them, we described our multidisciplinary approach with preliminary results of the first enrolled patients. METHODS: We included patients aged ≥ 18 years with hospital admission for confirmed SARS-CoV-2 infection. Symptoms were grouped in five macro groups hereafter referred to as "Symptoms Category" (SC): respiratory SC (dyspnoea or cough), neurological SC (peripheral neuropathies, headache, impaired mobility, behavioural disorders), psychological SC (sleep disorders, mood disorders), muscular SC (arthromyalgia, asthenia), other SC (fever, alopecia, diarrhoea, weight loss, smell and taste alterations, sexual dysfunctions). SC were evaluated at discharge and at follow-up. Association between patients’ characteristics and presence of SC at follow up was estimated by a logistic multivariable regression model. RESULTS: From June 2020 to July 2021, we followed up 361 patients: 128 (35.5%) who were previously admitted to Intensive Care Unit (ICU) and 233 patients to ordinary department. The median length of hospital stay was 20 days (Inter-Quartile-Range 13–32). Most patients (317/361, 87.8%) were still symptomatic at discharge, with one third referring three or more SC. At follow up, 67.3% (243/361) of patients still complained at least one SC. Moreover, 159 patients (44%) developed at least one new involved SC during follow up: 116 (72.9%) one SC, 39 (24.5%) two SC, 4 (2.5%) three or more SC. At follow up visit 130 of 361 (36%) were still with SC developed during follow up. At multivariable analysis presence of any SC at follow-up was associated with male gender (Odds Ratio [OR] 3.23, Confidence Interval [CI] 95% 1.46–7.15), ICU admission (OR 2.78, CI 95% 1.29–5.96) and presence of SC at discharge (OR 14.39, CI 95% 6.41–32.32). CONCLUSIONS: In our sample of patients with severe COVID-19, we found that PCC are highly variable and fluctuating over time; in particular, in about 50% of our patients new SC appear during follow up. Moreover, presence of PCC also in patients without SC at discharge and the variability of symptoms underlining the advisability of our multidisciplinary approach. Trial registration number: ClinicalTrials.gov Identifier: NCT04424992, registered on 28 February 2020 https://www.clinicaltrials.gov/ct2/results?recrs=ab&cond=&term=NCT04424992&cntry=&state=&city=&dist The current version of protocol is version 1.0 enrolling since June 2020. The enrollment is still ongoing. |
format | Online Article Text |
id | pubmed-9872735 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-98727352023-01-25 A multidisciplinary approach to screen the post-COVID-19 conditions Squillace, Nicola Cogliandro, Viola Rossi, Emanuela Bellelli, Giuseppe Pozzi, Matteo Luppi, Fabrizio Lettino, Maddalena Strepparava, Maria Grazia Ferrarese, Carlo Pollastri, Ester Ricci, Elena Bonfanti, Paolo BMC Infect Dis Research Article BACKGROUND: Post-COronaVIrus Disease 2019 (COVID-19) conditions (PCC) include multiple symptoms afflicting different organs and systems. To evaluate the frequency and type of them, we described our multidisciplinary approach with preliminary results of the first enrolled patients. METHODS: We included patients aged ≥ 18 years with hospital admission for confirmed SARS-CoV-2 infection. Symptoms were grouped in five macro groups hereafter referred to as "Symptoms Category" (SC): respiratory SC (dyspnoea or cough), neurological SC (peripheral neuropathies, headache, impaired mobility, behavioural disorders), psychological SC (sleep disorders, mood disorders), muscular SC (arthromyalgia, asthenia), other SC (fever, alopecia, diarrhoea, weight loss, smell and taste alterations, sexual dysfunctions). SC were evaluated at discharge and at follow-up. Association between patients’ characteristics and presence of SC at follow up was estimated by a logistic multivariable regression model. RESULTS: From June 2020 to July 2021, we followed up 361 patients: 128 (35.5%) who were previously admitted to Intensive Care Unit (ICU) and 233 patients to ordinary department. The median length of hospital stay was 20 days (Inter-Quartile-Range 13–32). Most patients (317/361, 87.8%) were still symptomatic at discharge, with one third referring three or more SC. At follow up, 67.3% (243/361) of patients still complained at least one SC. Moreover, 159 patients (44%) developed at least one new involved SC during follow up: 116 (72.9%) one SC, 39 (24.5%) two SC, 4 (2.5%) three or more SC. At follow up visit 130 of 361 (36%) were still with SC developed during follow up. At multivariable analysis presence of any SC at follow-up was associated with male gender (Odds Ratio [OR] 3.23, Confidence Interval [CI] 95% 1.46–7.15), ICU admission (OR 2.78, CI 95% 1.29–5.96) and presence of SC at discharge (OR 14.39, CI 95% 6.41–32.32). CONCLUSIONS: In our sample of patients with severe COVID-19, we found that PCC are highly variable and fluctuating over time; in particular, in about 50% of our patients new SC appear during follow up. Moreover, presence of PCC also in patients without SC at discharge and the variability of symptoms underlining the advisability of our multidisciplinary approach. Trial registration number: ClinicalTrials.gov Identifier: NCT04424992, registered on 28 February 2020 https://www.clinicaltrials.gov/ct2/results?recrs=ab&cond=&term=NCT04424992&cntry=&state=&city=&dist The current version of protocol is version 1.0 enrolling since June 2020. The enrollment is still ongoing. BioMed Central 2023-01-24 /pmc/articles/PMC9872735/ /pubmed/36694110 http://dx.doi.org/10.1186/s12879-023-08006-4 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Article Squillace, Nicola Cogliandro, Viola Rossi, Emanuela Bellelli, Giuseppe Pozzi, Matteo Luppi, Fabrizio Lettino, Maddalena Strepparava, Maria Grazia Ferrarese, Carlo Pollastri, Ester Ricci, Elena Bonfanti, Paolo A multidisciplinary approach to screen the post-COVID-19 conditions |
title | A multidisciplinary approach to screen the post-COVID-19 conditions |
title_full | A multidisciplinary approach to screen the post-COVID-19 conditions |
title_fullStr | A multidisciplinary approach to screen the post-COVID-19 conditions |
title_full_unstemmed | A multidisciplinary approach to screen the post-COVID-19 conditions |
title_short | A multidisciplinary approach to screen the post-COVID-19 conditions |
title_sort | multidisciplinary approach to screen the post-covid-19 conditions |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9872735/ https://www.ncbi.nlm.nih.gov/pubmed/36694110 http://dx.doi.org/10.1186/s12879-023-08006-4 |
work_keys_str_mv | AT squillacenicola amultidisciplinaryapproachtoscreenthepostcovid19conditions AT cogliandroviola amultidisciplinaryapproachtoscreenthepostcovid19conditions AT rossiemanuela amultidisciplinaryapproachtoscreenthepostcovid19conditions AT bellelligiuseppe amultidisciplinaryapproachtoscreenthepostcovid19conditions AT pozzimatteo amultidisciplinaryapproachtoscreenthepostcovid19conditions AT luppifabrizio amultidisciplinaryapproachtoscreenthepostcovid19conditions AT lettinomaddalena amultidisciplinaryapproachtoscreenthepostcovid19conditions AT strepparavamariagrazia amultidisciplinaryapproachtoscreenthepostcovid19conditions AT ferraresecarlo amultidisciplinaryapproachtoscreenthepostcovid19conditions AT pollastriester amultidisciplinaryapproachtoscreenthepostcovid19conditions AT riccielena amultidisciplinaryapproachtoscreenthepostcovid19conditions AT bonfantipaolo amultidisciplinaryapproachtoscreenthepostcovid19conditions AT amultidisciplinaryapproachtoscreenthepostcovid19conditions AT squillacenicola multidisciplinaryapproachtoscreenthepostcovid19conditions AT cogliandroviola multidisciplinaryapproachtoscreenthepostcovid19conditions AT rossiemanuela multidisciplinaryapproachtoscreenthepostcovid19conditions AT bellelligiuseppe multidisciplinaryapproachtoscreenthepostcovid19conditions AT pozzimatteo multidisciplinaryapproachtoscreenthepostcovid19conditions AT luppifabrizio multidisciplinaryapproachtoscreenthepostcovid19conditions AT lettinomaddalena multidisciplinaryapproachtoscreenthepostcovid19conditions AT strepparavamariagrazia multidisciplinaryapproachtoscreenthepostcovid19conditions AT ferraresecarlo multidisciplinaryapproachtoscreenthepostcovid19conditions AT pollastriester multidisciplinaryapproachtoscreenthepostcovid19conditions AT riccielena multidisciplinaryapproachtoscreenthepostcovid19conditions AT bonfantipaolo multidisciplinaryapproachtoscreenthepostcovid19conditions AT multidisciplinaryapproachtoscreenthepostcovid19conditions |